Evidence map›Paper›PMID 29700111›Full record

ArticleThe Journal of biological chemistry2018

Disruption of an oligomeric interface prevents allosteric inhibition of

Percival Yang-Ting Chen, Michael A Funk, Edward J Brignole, Catherine L Drennan

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Hypermutability ofEmerging microbes & infections · 2025
    Article
  2. Article
  3. Profile of Catherine Drennan.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. 2.6-Å resolution cryo-EM structure of a class Ia ribonucleotide reductase trapped with mechanism-based inhibitor NProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Basis of dATP inhibition of RNRs.The Journal of biological chemistry · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Percival Yang-Ting ChenFrom the Departments of Chemistry and.
Michael A FunkFrom the Departments of Chemistry and.
Edward J BrignoleFrom the Departments of Chemistry and.
Catherine L DrennanFrom the Departments of Chemistry and cdrennan@mit.edu.
Massachusetts Institute of Technology · USHoward Hughes Medical Institute · US

Funding

TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LEVINE, STUART S · 1985 to 2020
$25.6M
Howard Hughes Medical InstituteNIEHS NIH HHS P30 ES002109
6 · The paper itself

Abstract

Ribonucleotide reductases (RNRs) convert ribonucleotides to deoxynucleotides, a process essential for DNA biosynthesis and repair. Class Ia RNRs require two dimeric subunits for activity: an α

Indexed as

Amino Acid SubstitutionAllosteric RegulationDeoxyadenine NucleotidesEscherichia coliModels, MolecularProtein MultimerizationProtein Structure, QuaternaryRibonucleotide Reductases2'-deoxyadenosine triphosphateDeoxyadenine NucleotidesRibonucleotide Reductasesallosteric inhibitionallosteric regulationmutagenesis mechanismnucleoside/nucleotide biosynthesisprotein–protein interactionradical-based chemistryribonucleotide reductasetyrosyl radical cofactorα4β4 ring

Identifiers

PMID29700111
PMCPMC6028975
OpenAlexW2802321574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.